Unilever Targets €1.5B in GLP-1 Boosting Plant-Based Food Sales by 2025 to Help Consumers Boost Gut Health

Unilever is aiming to reach €1.5B in annual sales from plant-based products by 2025 to help consumers boost gut health through a natural Ozempic effect. The company plans to double the number of products with healthy ingredients like vegetables and fruits, which currently make up 48% of its total portfolio. Research suggests that plant-based diets can improve the gut microbiome, promoting the production of incretin hormones that control appetite and metabolism similar to drugs like Ozempic and Wegovy.

Unilever's focus on plant-based foods aligns with consumer trends towards healthier eating habits. By offering a wide range of vegan products across its brands, the company aims to support its Positive Nutrition strategy while promoting increased consumption of produce. As more consumers recognize the link between gut health and overall wellness, Unilever's efforts to incorporate scientific insights into plant-based food innovations could help make plant-based eating a more appetizing option for consumers worldwide.